Zobrazeno 1 - 10
of 923
pro vyhledávání: '"Dergunov, A."'
Autor:
Anton V. Snegovoy, Inessa B. Kononenko, Irina M. Radiukova, Svetlana A. Orlova, Alexander V. Sultanbaev, Daria M. Dubovichenko, Aleksandr S. Dergunov, Aleksandra F. Saidullaeva, Nadezhda N. Repina, Iuliia A. Gronskaia, Elena I. Rossokha, Tatiana V. Starostina, Oksana V. Akimova, Iuliia A. Vasil'eva, Zarina A. Godzhieva, Ol'ga Iu. Garanina, Khava I. Gorchkhanova, Iuliia S. Machekhina, Aleksandra S. Gracheva, Anastasiia E. Danilova, Tat'iana N. Dmitrakova, Vadim N. Dmitriev, Marina V. Dmitrochenko, Olga V. Dylinova, Viktoriia O. El'kova, Alla V. Zhelezniak, Irina V. Zubova, Aleksandr N. Ivanov, Liliia P. Kaleikina, Iuliia V. Komoza, Dmitrii N. Korolev, Liudmila N. Lebedeva, Andrei A. Lebedinets, Naira N. Mamedguseinova, Valeriia S. Miagkova, Elena I. Matiushina, Kristina V. Narovenkova, Valentina M. Nikolaeva, Denis V. Novikov, Galina E. Polonskaia, Olesia V. Rebrina, Mariia A. Safronova, Anna S. Semenova, Inessa A. Semenova, Roman A. Skotnikov, Ekaterina P. Solov'eva, Anna N. Tat'ianenko, Antonina A. Teterich, Vladimir N. Timin, Irina A. Tolmacheva, Iana A. Tiugina, Aleksandra V. Khodkevich, Fatima V. Tsarakhova, Iana S. Chapko, Margarita M. Shegurova, Nadezhda R. Shakurova, Anna I. Shalina, Elena A. Shumilkina, Daria V. Iakuba, Tansylu M. Ibragimova, Polina S. Feoktistova, Irina V. Sorokina, Anna M. Berezina, Polina V. Kiseleva, Olga N. Mironenko, Oxana N. Prosianikova
Publikováno v:
Современная онкология, Vol 26, Iss 2, Pp 159-171 (2024)
Aim. To evaluate the effectiveness and safety of Extimia® (empegfilgrastim, JSC "BIOCAD") in reducing the frequency, duration of neutropenia, the incidence of febrile neutropenia (FN) and infections caused by FN in patients with solid tumors receivi
Externí odkaz:
https://doaj.org/article/cbf44cb884d749adae40ccde298bbf78
Autor:
Maria I. Volkova, Alexey S. Kalpinskiy, Olesya A. Goncharova, Konstantin V. Menshikov, Elena V. Karabina, Aleksand S. Dergunov, Natalya I. Polshina, Elena N. Alexandrova, Andrey A. Lebedinets, Alexey К. Panov, Alexander V. Sultanbaev, Evgeny A. Usynin, Mikhail V. Volkonskiy, Viktorya V. Mikhalyuk, Ruslan A. Zukov, Yulia V. Anzhiganova, Magomed A. Gusniev, Elena N. Igumnova, Svetlana V. Kuzmicheva, Ilya A. Pokataev, Anna S. Olshanskaya, Natalia I. Pervakova, Elvira L. Parsadanova, Tatyana A. Sannikova, Alexandr A. Bystrov, Daria M. Dubovichenko, Mukhitova R. Miliausha, Viacheslav A. Chubenko, Konstantin A. Shkret, Mariya N. Gorshenina, Mavzhuda К. Davlatova, Alina E. Kosareva, Olga A. Lutoshkina, Oxana A. Maslova, Maria V. Makhnutina, Anna V. Mishina, Makhabbat Zh. Murzalina, Oksana A. Podyacheva, Sergey A. Kalinin, Ovsep A. Mailyan, Alfiya R. Safarova, Ksenia O. Semenova, Mariya A. Strokova, Ekaterina Yu. Urashkina, Olesya S. Shmygina
Publikováno v:
Современная онкология, Vol 26, Iss 1, Pp 39-47 (2024)
Aim To evaluate the safety and toxicity of lenvatinib with pembrolizumab in unselected patients with advanced renal cell carcinoma (RCC). Materials and methods. The Russian phase IV observational study included 151 patients with advanced RCC who r
Externí odkaz:
https://doaj.org/article/b8f04fb084054d4fa93d3b87907a155b
Autor:
Kristina V. Orlova, Mikhail Iu. Fedyanin, Konstantin E. Simanenkov, Aleksandr S. Dergunov, Petr R. Goldshmidt, Aleksandra F. Saydullaeva, Darya V. Bogacheva, Marina A. Yavorskaya, Artur Z. Azanov, Alexander A. Fedenko, Larisa V. Bolotina, Tatyana I. Deshkina, Kseniya G. Babina, Ekaterina A. Kuzevanova, Liudmila G. Zhukova, Polina S. Feoktistova, Natalya I. Polshina, Ekaterina V. Peganova, Valentina E. Shikina, Maksim M. Sobolev, Oleg V. Mironov, Vera A. Vaschenko, Mariya M. Ershova, Agniya O. Mezhueva, Svetlana A. Orlova, Denis A. Tantsyrev, Darya K. Taskina, Antonina A. Teterich, Elena V. Karabina, Yuliya V. Kostalanova, Marina V. Bogacheva, Natalia V. Zhukova, Rashida V. Orlova, Maksim V. Zinkevich, Aleksandr I. Kazmin, Mikhail V. Volkonskiy, Liya M. Voronkova, Anastasiya S. Karpova, Mikhail L. Maleyko, Mariya N. Gorshenina, Elena I. Kryuchkova, Fedor V. Moiseenko, Yuliya I. Murzina, Shamil I. Musin, Andrey N. Ogloblin, Mariya S. Perminova, Regina A. Dumbrava, Sergey A. Emelyanov, Svetlana A. Protsenko, Alexander V. Sultanbaev, Anna V. Tarasova, Elena B. Shakhnovich, Marina V. Demchenkova, Yuliya A. Lozovskaya, Khedi S. Musaeva, Elena M. Pavlova, Roman A. Skotnikov, Vera V. Chernova, Angelina S. Chichkanova, Adina M. Akhmatova, Marina A. Zafirova, Andrey A. Mischenko, Elena N. Ovsienko, Viktoriya A. Petrukhnenko, Oksana A. Syusyukaylova, Yana A. Tyugina, Elena A. Shumilkina, Daniil L. Stroyakovskiy, Aleksandr N. Yurchenkov, Pavel L. Baldin, Anastasiya S. Belova, Olga V. Diduk, Elena A. Konovalova, Lyudmila N. Lebedeva, Yaroslav A. Li, Viktoriya V. Mashtapa, Yana A. Mironenkova, Kristina V. Narovenkova, Olga A. Pavlikova, Elvira L. Parsadanova, Irina S. Pimonova, Anna A. Ruzhnikova, Irina D. Sivunova, Ekaterina P. Soloveva, Maksim I. Sosnin, Kh. Toita Temirsultanova, Makhabbat Zh. Tyulegenova, Aleksandra V. Khodkevich, Nadezhda R. Shakurova, Sureya N. Efendieva, Karine L. Avagimyan, Ekaterina Р. Anokhina, Mariya I. Antoshkina, Stanislav M. Borzyanitsa, Samir K. Dzhentemirov, Marina V. Dmitrochenko, Alla V. Zheleznyak, Yuliya V. Komoza, Aleksandr S. Kopanev, Tatyana I. Kornienko, Margarita A. Krasilnikova, Darya A. Lukhmanova, Natalya S. Mazur, Polina M. Markina, Zhargal S. Mitapov, Svetlana N. Osodoeva, Irina A. Prokopenko, Irina M. Radyukova, Madina S. Ramazanova, Alfiya R. Safarova, Mariya A. Safronova, Khalimat M. Khabrieva, Natalya S. Tsygankova, Kseniya V. Chermakova, Tatyana A. Chirkova, Igor V. Samoylenko, Valeria V. Nazarova, Angelina E. Akhmetyanova, Lev V. Demidov
Publikováno v:
Современная онкология, Vol 26, Iss 1, Pp 20-34 (2024)
Background. Prior to the introduction of new agents — immune checkpoint inhibitors — for inoperable and/or metastatic melanoma (IMM), chemotherapy outcomes were generally poor. The median (Me) overall survival (OS) in IMM was no more than 6-9 mon
Externí odkaz:
https://doaj.org/article/fff40d04a39d498ba7ec6262154c7020
Autor:
Alexander D. Dergunov, Elena V. Nosova, Alexandra V. Rozhkova, Margarita A. Vinogradina, Veronika B. Baserova, Mikhail A. Popov, Svetlana A. Limborska, Liudmila V. Dergunova
Publikováno v:
Frontiers in Bioscience-Landmark, Vol 29, Iss 11, p 396 (2024)
Background: The associations of high-density lipoprotein (HDL) level and functionality with lipid metabolism, inflammation, and innate immunity in coronary artery disease (CAD) remain controversial. The differential expression of a set of genes relat
Externí odkaz:
https://doaj.org/article/d7b98a272f444b4d854e59414d05c376
Publikováno v:
Voprosy kiberbezopasnosti.2022.1(47).p.49-65
Objective. Insecure Direct Object Reference (IDOR) or Broken Object Level Authorization (BOLA) are one of the critical type of access control vulnerabilities for modern applications. As a result, an attacker can bypass authorization checks leading to
Externí odkaz:
http://arxiv.org/abs/2201.10833
Autor:
Liudmila V. Dergunova, Margarita A. Vinogradina, Ivan B. Filippenkov, Svetlana A. Limborska, Alexander D. Dergunov
Publikováno v:
Current Issues in Molecular Biology, Vol 45, Iss 8, Pp 6682-6700 (2023)
Over the past decade, numerous studies have shown that circular RNAs (circRNAs) play a significant role in coronary artery atherogenesis and other cardiovascular diseases. They belong to the class of non-coding RNAs and arise as a result of non-canon
Externí odkaz:
https://doaj.org/article/9a3c847cd97e48b7bb9f1f368822c743
Autor:
Alexander D. Dergunov, Elena V. Nosova, Alexandra V. Rozhkova, Margarita A. Vinogradina, Veronika B. Baserova, Mikhail A. Popov, Svetlana A. Limborska, Liudmila V. Dergunova
Publikováno v:
Current Issues in Molecular Biology, Vol 45, Iss 8, Pp 6823-6841 (2023)
Differential expression of genes (DEGs) in coronary artery disease (CAD) and the association between transcript level and high-density lipoprotein cholesterol (HDL-C) were studied with 76 male patients with CAD and 63 control patients. The transcript
Externí odkaz:
https://doaj.org/article/25aeb1fae43640e9b42a0e5f2d2a4d3f
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.